Impulse Biomedical Joins Maryland Global Gateway Soft Landing Program
Impulse Biomedical, a healthcare company based in Cape Town, has been accepted into the Maryland Global Gateway Soft Landing Program, which supports its global expansion. The company develops products aimed at improving asthma and allergy care, including the ZiBiPen® autoinjector and Easy Squeezy® asthma device.
CAPE TOWN, South Africa–(BUSINESS WIRE)–Impulse Biomedical, a Cape Town-based healthcare company focused on advancing asthma and allergy care through developing more accessible and patient-focused products, is excited to announce its acceptance into the Maryland Global Gateway Soft Landing Program, which marks a major milestone in its global expansion plans. The company, focused on developing and commercializing its patented ZiBiPen® reloadable autoinjector and patented Easy Squeezy® asthma a